RN

Randall Nelson

Cardiex Limited | Non-Executive Director
Mr Nelson brings more than 30 years of diverse experience and expertise with medical devices. He is a former President and CEO of Uptake Medical Corporation, a company focused on treatments for emphysema and lung cancer. Previously, he served as president and CEO of Kerberos Proximal Solutions, which was acquired by FoxHollow Technologies, and as president and CEO of VenPro, a heart valve business acquired by Medtronic. Both these companies specialised in devices for the cardiovascular system. Prior to that, he spent 19 years with Baxter International and American Hospital Supply Corporation in roles of increasing responsibility that included division president for Dade Diagnostics, Bentley Labs, and Baxter's Perfusion Services. King is also currently CEO of Q'Apel Medical - a medical device company focused on Neurovascular disease. He is member of Risk Committee.

Company and Role

Company
Title
Tenure
Since
CDX
CDX
Cardiex Limited
  • Non-Executive Director
9yrs, 6mthNov 2015

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
CDX
CDX
Cardiex Limited
30/12/2415,385N/A1,500,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
CDX
CDX
Cardiex Limited
30/12/24
Issued
1,000,000$0.096$96,000Issue of options
CDX
CDX
Cardiex Limited
26/02/24
Cancelled
350,000$0.081$28,350Cancellation of securities
CDX
CDX
Cardiex Limited
26/02/24
Expiry
150,000$0.081$12,150Options expired
CDX
CDX
Cardiex Limited
12/01/21
Issued
3,500,000$0.078$273,000Issue of securities
CDX
CDX
Cardiex Limited
23/12/16
Buy
153,846$0.065$9,999As advised by the company. Share purchase as approved by shareholders on 21 December 2016.